LHX vs MGRX · P/E 34, rev $5.88B vs rev $456.0K
L3Harris Technologies Inc (LHX) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the LHX and MGRX stock pages for the full models.
Not investment advice.